Skip to navigation Skip to content

Opioids, prescriptions and approvals in the Pharmaceutical Benefits Scheme (PBS) 012-20101406



Scenarios

Table 1

Item

Description

1

A Service Officer receives a request from a prescriber wanting a quantity that would require a pack to be broken.

The Service Officer can provide approval if the quantity and any repeats does not exceed a maximum of one month's supply via phone, or 3 months’ supply (in OPA or in writing, either by post or HPOS form upload only).

2

A prescriber contacts to ask what opioid-naive is.

The Service Officer explains opioid naive refers to a patient's previous use of opioids. For the purposes of a PBS approval, a patient is opioid naive if they have not consistently used opioids.

3

A patient is prescribed methadone to treat long-term pain.

Only the length of treatment for pain management is considered. When the patient's opioid treatment is more than 12 months the prescriber must provide the length of time for the opioid treatment. The prescriber must also make sure another medical practitioner consults with the patient about the continuing need for opioid treatment.

Note: Methadone is not always prescribed to treat pain. It is sometimes prescribed for opioid dependence. However, this does not affect treatment length for pain management approvals.

4

A patient has a new prescriber, who will be their regular doctor in the future.

Their doctor can be the reviewing prescriber. However, after 12 months a different prescriber will need to do a new opioid (narcotic) review.

Scenarios - duration of treatment

Table 2

Item

Description

1

A patient has never had an authority prescription for opioid treatment. Is their treatment duration defined as less than 12 months?

No, the agency needs to consider the total length of opioid treatment.

This may include non-PBS treatment, PBS treatment with listed amounts and PBS treatment supplied under an authority for increased quantities and repeats. Medicines such as tramadol and paracetamol plus codeine combinations are considered opioid treatment and must be reviewed by the prescriber.

Review of patient opioid treatment for pain management

Table 3

Item

Description

1

In certain circumstances an authority for increased quantity and repeats can be approved

If a patient:

  • has proven malignant neoplasia. Note: not all opioids have this option, or
  • is in palliative care and they cannot attend a review due to their condition

The authority application must not be approved if:

  • the length of the patient’s opioid treatment is more than 12 months
  • they have not had a review in the last 12 months, and
  • a review is not planned in the next 3 months

The prescriber may write a PBS prescription for the listed quantity.